Landos Biopharma Inc (LABP)
22.46
+0.16
(+0.72%)
USD |
NASDAQ |
May 17, 16:00
22.46
0.00 (0.00%)
After-Hours: 20:00
Landos Biopharma Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.063M |
| September 30, 2023 | 0.634M |
| June 30, 2023 | 3.974M |
| March 31, 2023 | 3.104M |
| December 31, 2022 | 11.47M |
| September 30, 2022 | 17.21M |
| June 30, 2022 | 25.87M |
| March 31, 2022 | 19.51M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.796M |
| September 30, 2021 | 10.83M |
| June 30, 2021 | 0.715M |
| March 31, 2021 | -72.05M |
| December 31, 2020 | 6.93M |
| September 30, 2020 | 3.464M |
| June 30, 2020 | 2.03M |
| March 31, 2020 | 1.707M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-72.05M
Minimum
Mar 2021
25.87M
Maximum
Jun 2022
2.192M
Average
3.104M
Median
Mar 2023
Cash from Investing (Quarterly) Benchmarks
| AbbVie Inc | -9.588B |
| Fusion Pharmaceuticals Inc | -70.37M |
| Masimo Corp | -18.90M |
| Kinnate Biopharma Inc (DELISTED) | 22.70M |
| Invivyd Inc | -0.14M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.498M |
| Free Cash Flow | -20.80M |
| Free Cash Flow Per Share (Quarterly) | -1.369 |
| Free Cash Flow Yield | -14.92% |